Maxcyte (MXCT) Return on Assets (2021 - 2025)
Historic Return on Assets for Maxcyte (MXCT) over the last 5 years, with Q3 2025 value amounting to 0.21%.
- Maxcyte's Return on Assets fell 700.0% to 0.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.16% for FY2024, which is 300.0% down from last year.
- Per Maxcyte's latest filing, its Return on Assets stood at 0.21% for Q3 2025, which was down 700.0% from 0.2% recorded in Q2 2025.
- In the past 5 years, Maxcyte's Return on Assets registered a high of 0.06% during Q1 2022, and its lowest value of 0.21% during Q3 2025.
- Its 5-year average for Return on Assets is 0.13%, with a median of 0.14% in 2024.
- Its Return on Assets has fluctuated over the past 5 years, first surged by 100bps in 2022, then tumbled by -700bps in 2025.
- Quarter analysis of 5 years shows Maxcyte's Return on Assets stood at 0.07% in 2021, then decreased by -21bps to 0.08% in 2022, then crashed by -72bps to 0.14% in 2023, then fell by -19bps to 0.17% in 2024, then dropped by -25bps to 0.21% in 2025.
- Its Return on Assets was 0.21% in Q3 2025, compared to 0.2% in Q2 2025 and 0.18% in Q1 2025.